Toxicities and outcomes of 616 ibrutinib-treated patients in ... - PMC
Explain the specific (toxicities) that led to these discontinuations. Compare these results to more recent ibrutinib studies .
: Both groups had roughly the same time (about 85–87 months) from their initial diagnosis until they started ibrutinib treatment. Clinical Implications
